New diabetes clinical trial: Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

Published on: September 22, 2020 at 09:30PM
Condition:   Coronary Atherosclerosis
Intervention:   Device: continuous glucose monitoring (CGM)
Sponsor:   National Cerebral and Cardiovascular Center
Recruiting
https://ift.tt/35Srdyi